CHARMAN 375101 Orally Administered Nanotherapeutics For Parkinson's Disease

Product Description

CHARMAN 375101 is designed for research on orally administered nanotherapeutics aimed at Parkinson's disease. This product addresses the challenges faced by standard therapies, particularly with transport limitations across the blood-brain barrier and hepatic metabolism. The application of nanotechnology seeks to enhance drug delivery through the oral route, leveraging nanocarriers such as nanoparticles and lipid nanoparticles. These technologies aim to optimize drug bioavailability and improve therapeutic outcomes.

• Focuses on orally administered nanotherapeutics.
• Designed for Parkinson's disease research.
• Explores nanotechnology to improve drug delivery.

Product Highlights

Product Information

Standard Information

• Brand: CHARMAN
• MPN: 375101

Technical Specifications

• Research Focus: Parkinson's Disease
• Delivery Method: Orally Administered
• Nanotechnology: Utilizes nanocarriers